These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33484625)
1. Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial. Lian JX; McGhee SM; So C; Kwong ASK; Sum R; Tsui WWS; Chao DVK; Chan JCH J Diabetes Investig; 2021 Sep; 12(9):1632-1641. PubMed ID: 33484625 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Lee KM; Sum WM Clin Exp Optom; 2011 Jul; 94(4):371-5. PubMed ID: 21323731 [TBL] [Abstract][Full Text] [Related]
3. Incentives in Diabetic Eye Assessment by Screening (IDEAS): study protocol of a three-arm randomized controlled trial using financial incentives to increase screening uptake in London. Judah G; Vlaev I; Gunn L; King D; King D; Valabhji J; Darzi A; Bicknell C BMC Ophthalmol; 2016 Mar; 16():28. PubMed ID: 26993471 [TBL] [Abstract][Full Text] [Related]
4. Screening for diabetic retinopathy with or without a copayment in a randomized controlled trial: influence of the inverse care law. Lian JX; McGhee SM; Gangwani RA; Hedley AJ; Lam CL; Yap MK; Lai WW; Chu DW; Wong DS Ophthalmology; 2013 Jun; 120(6):1247-53. PubMed ID: 23583166 [TBL] [Abstract][Full Text] [Related]
5. Community-based diabetic retinopathy screening in Hong Kong: ocular findings. Fung MM; Yap MK; Cheng KK Clin Exp Optom; 2011 Jan; 94(1):63-6. PubMed ID: 21198835 [TBL] [Abstract][Full Text] [Related]
6. Vibration perception threshold for sight-threatening retinopathy screening in type 2 diabetic outpatients. Shen J; Hu Y; Liu F; Zeng H; Li L; Zhao J; Zhao J; Zheng T; Lu H; Lu F; Bao Y; Jia W Diabetes Metab Res Rev; 2013 Oct; 29(7):525-31. PubMed ID: 23658123 [TBL] [Abstract][Full Text] [Related]
7. Financial disincentives? A three-armed randomised controlled trial of the effect of financial Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial. Judah G; Darzi A; Vlaev I; Gunn L; King D; King D; Valabhji J; Bicknell C Br J Ophthalmol; 2018 Aug; 102(8):1014-1020. PubMed ID: 29793929 [TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy screening: global and local perspective. Gangwani RA; Lian JX; McGhee SM; Wong D; Li KK Hong Kong Med J; 2016 Oct; 22(5):486-95. PubMed ID: 27562988 [TBL] [Abstract][Full Text] [Related]
9. Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project. Brazionis L; Jenkins A; Keech A; Ryan C; Brown A; Boffa J; Bursell S; Diabet Med; 2018 May; 35(5):630-639. PubMed ID: 29405370 [TBL] [Abstract][Full Text] [Related]
10. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study. Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP; Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513 [TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. Scanlon PH; Carter SC; Foy C; Husband RF; Abbas J; Bachmann MO J Med Screen; 2008; 15(3):118-21. PubMed ID: 18927093 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Tam TK; Lau CM; Tsang LC; Ng KK; Ho KS; Lai TC Hong Kong Med J; 2005 Dec; 11(6):438-44. PubMed ID: 16340019 [TBL] [Abstract][Full Text] [Related]
13. Incidence of diabetic retinopathy in a Hong Kong Chinese population. Song H; Liu L; Sum R; Fung M; Yap MK Clin Exp Optom; 2011 Nov; 94(6):563-7. PubMed ID: 21790780 [TBL] [Abstract][Full Text] [Related]
14. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review. Groeneveld Y; Tavenier D; Blom JW; Polak BCP Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170 [TBL] [Abstract][Full Text] [Related]
15. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP; Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763 [TBL] [Abstract][Full Text] [Related]
16. Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use. Keenum Z; McGwin G; Witherspoon CD; Haller JA; Clark ME; Owsley C JAMA Ophthalmol; 2016 Nov; 134(11):1221-1228. PubMed ID: 27632231 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950 [TBL] [Abstract][Full Text] [Related]
18. Use of Telehealth Screening to Detect Diabetic Retinopathy and Other Ocular Findings in Primary Care Settings. Gao X; Park CH; Dedrick K; Borkar DS; Obeid A; Reber S; Federman J Telemed J E Health; 2019 Sep; 25(9):802-807. PubMed ID: 30481134 [No Abstract] [Full Text] [Related]
19. Effect of prepaid and promised financial incentive on follow-up survey response in cigarette smokers: a randomized controlled trial. Cheung YTD; Weng X; Wang MP; Ho SY; Kwong ACS; Lai VWY; Lam TH BMC Med Res Methodol; 2019 Jul; 19(1):138. PubMed ID: 31272393 [TBL] [Abstract][Full Text] [Related]